BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6211227)

  • 1. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
    Abul-Hajj YJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3373s-3377s. PubMed ID: 6211227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen synthesis in human breast tumor and its inhibition by testololactone and bromoandrostenedione.
    Dao TL
    Cancer Res; 1982 Aug; 42(8 Suppl):3338s-3341s. PubMed ID: 7083197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
    MacIndoe JH; Woods GR; Etre LA; Covey DF
    Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Wing LY; Garrett WM; Brodie AM
    Cancer Res; 1985 Jun; 45(6):2425-8. PubMed ID: 3921242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of recent development of aromatase inhibitors.
    Brodie AM
    Cancer Res; 1982 Aug; 42(8 Suppl):3312s-3314s. PubMed ID: 7083192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of aromatase activity in human breast cancer.
    Miller WR; Hawkins RA; Forrest AP
    Cancer Res; 1982 Aug; 42(8 Suppl):3365s-3368s. PubMed ID: 7083201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
    Sonne-Hansen K; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
    Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor.
    Santen RJ; Santner SJ; Tilsen-Mallett N; Rosen HR; Samojlik E; Veldhuis JD
    Cancer Res; 1982 Aug; 42(8 Suppl):3353s-3359s. PubMed ID: 7083200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione in MCF-7 human mammary carcinoma cell culture.
    Brueggemeier RW; Katlic NE
    Cancer Res; 1987 Sep; 47(17):4548-51. PubMed ID: 3621153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
    Covey DF; Hood WF
    Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological significance of aromatase activity in human breast tumors.
    Tilson-Mallett N; Santner SJ; Feil PD; Santen RJ
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1125-8. PubMed ID: 6630410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted C19 steroid analogs as inhibitors of aromatase.
    Brueggemeier RW; Snider CE; Counsell RE
    Cancer Res; 1982 Aug; 42(8 Suppl):3334s-3337s. PubMed ID: 7083196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of aminoglutethimide: structure/activity relationships and receptor interactions.
    Nicholls PJ; Daly MJ; Smith HJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S55-67. PubMed ID: 3755630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of peripheral aromatization by aromatase inhibitors, 4-hydroxy- and 4-acetoxy-androstene-3,17-dione.
    Brodie AM; Longcope C
    Endocrinology; 1980 Jan; 106(1):19-21. PubMed ID: 6765930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Growth inhibition of MCF-7 human breast cancer cells by aromatase inhibitors].
    Fukuoka M; Kitawaki J; Yamamoto T; Okada H
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Dec; 43(12):1667-73. PubMed ID: 1836000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
    Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
    Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatase in human breast carcinoma.
    Perel E; Blackstein ME; Killinger DW
    Cancer Res; 1982 Aug; 42(8 Suppl):3369s-3372s. PubMed ID: 7083202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of androgen aromatization in human breast cancer.
    Abul-Hajj YJ
    J Steroid Biochem; 1980 Dec; 13(12):1395-400. PubMed ID: 7464118
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
    Kellis JT; Vickery LE
    Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.